Shannon Blalock

Directeur Général chez jCyte, Inc.

Health Technology

Consumer Services

Health Services

Postes actifs de Shannon Blalock

Sociétés	Poste	Début	Fin
jCyte, Inc. jCyte, Inc. Medical/Nursing ServicesHealth Services jCyte, Inc. engages in the provision of retinal therapies. Its therapy focuses with retinitis pigmentosa, and retinal progenitor cells. The company was founded by Terry O?Neal, Henry Klassen and Jing Yang in 2012 and is headquartered in Newport Beach, CA.	Directeur/Membre du Conseil	08/02/2021	-
	Directeur Général	08/02/2021	-
	Directeur des opérations	-	08/02/2021

Sociétés	Poste	Début	Fin
ALTHEADX INC	Corporate Officer/Principal	-	28/11/2014
GSK PLC	Sales & Marketing	-	-

The University of North Carolina at Charlotte

Doctorate Degree

Internationale

Etats-Unis	4
Royaume-Uni	2

Opérationnelle

Corporate Officer/Principal	1
Sales & Marketing	1
Doctorate Degree	1

Sectorielle

Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Sociétés cotées	1
GSK PLC	Health Technology

Entreprise privées	2
AltheaDx, Inc. AltheaDx, Inc. Pharmaceuticals: MajorHealth Technology AltheaDx, Inc. operates as a commercial stage molecular diagnostics company which specializes in pharmacogenetics. It focuses in depression and anxiety, clinical publications, and IDgenetix testing process. The company was founded by Francois Ferre and Magda Marquet and is headquartered in San Diego, CA.	Health Technology
jCyte, Inc. jCyte, Inc. Medical/Nursing ServicesHealth Services jCyte, Inc. engages in the provision of retinal therapies. Its therapy focuses with retinitis pigmentosa, and retinal progenitor cells. The company was founded by Terry O?Neal, Henry Klassen and Jing Yang in 2012 and is headquartered in Newport Beach, CA.	Health Services